Since 1996, approximately 1,000 patients have received an autologous hematopoietic stem
cell transplant (HSCT) as treatment for a severe autoimmune disease (AD). The European …

Ten years have passed since the first published consensus statement on the use of
hematopoietic stem cell transplantation (HSCT) in the treatment of severe autoimmune …

Over the past 15 years, more than 1500 patients have received HSCT, mostly autologous, as
treatment for a severe autoimmune disease (AD). More than 1000 of these have been …

Current systemic therapies are rarely curative for patients with severe life-threatening forms
of autoimmune disease (AID). During the past 15 years, autologous hematopoietic stem cell …

Much progress has been made in the field of haemopoietic stem cell transplants (HSCTs) for
severe autoimmune disorders. Theoretical considerations, animal data and anecdotal …

Background Autologous hematopoietic stem cell transplantation has been used since 1996
for the treatment of severe autoimmune diseases refractory to approved therapies. We …

Autologous stem cell transplantation (ASCT) is starting to be investigated as a potential
therapy for severe refractory autoimmune disease including rheumatological, neurological …

Hematopoietic stem cell transplantation is becoming an accepted therapy for severe
autoimmune diseases, and over 1000 patients have been transplanted worldwide. Diseases …

Abstract Since Morton and Siegel's epochal experiments 30 years ago animal models have
been successfully utilized both for transfer and resolution of autoimmune diseases (AID) …

Around 700 patients have received an autologous haematopoietic stem cell transplant
(HSCT) as treatment for a severe autoimmune disease (AD). The majority of these have …